DrFirst, one of the members of the E-Prescribing of Controlled Substances (EPCS) pilot program, has just been featured in MDNG’s Pain Management magazine.
Along with a team of dedicated and innovative industry leaders, DrFirst helped pioneer the new technology and workflows needed for the DEA to issue an interim final rule governing the e-prescribing of controlled substances. Now with the interim final rule announced, the topic is getting even hotter as Pain Management magazine digs deep into the inner workings of the program and how a system such as Rcopia will one day be the norm for doctors across the country.
About ifroehlich:
Ms. Froehlich has been with DrFirst since its inception in 2000. In her role as Director of Marketing, she oversees the planning, directing, and coordinating all marketing and public relations efforts at DrFirst. Ms. Froehlich has a B.S. in Communications from the University of Illinois, Champaign-Urbana.
Both comments and pings are currently closed.
